Improved diagnostics of cerebral gliomas using FET PET;Verbesserte Diagnostik von zerebralen Gliomen mit der FET PET

Zeitschrift fur Medizinische Physik

Volumn 17, Issue 4, 2007, Pages 237-241

  Langen, Karl Josef ^a,c   Floeth, Frank W ^b   Stoffels, Gabriele ^a,c   Hamacher, Kurt ^a,c   Coenen, Heinz H ^a,c   Pauleit, Dirk ^a,c  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c Brain Imaging Center West   (Germany)

Author keywords

Amino Acid PET; Brain tumors

Indexed keywords

2 (2 FLUOROETHYL)TYROSINE F 18; TRACER; UNCLASSIFIED DRUG;

ARTICLE; BIOPSY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; GERMANY; GLIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS;

EID: 36749081540     PISSN: 09393889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.zemedi.2006.08.001     Document Type: Article

References (31)

1. Floeth F, Reifenberger G, Langen KJ, Pauleit D, Steiger HJ, Sabel M. Prognostic value of amino-acid PET with FET in 85 patients with newly diagnosed glioma-suspicious [1] intracerebral lesions. 56. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie e.V. (DGNC), 3èmes journées françaises de Neurochirurgie (SFNC). Strasbourg, 07. - 11.05.2005 〈www.egms.de//en/meetings/dgnc2005/05dgnc0126.shtml〉
2. Floeth F., Pauleit D., Wittsack H.J., Langen K.J., Reifenberger G., Hamacher K., et al. Multimodal metabolic imaging of cerebral gliomas using positron emission tomography with [18F]-fluoroethyl-l-tyrosine and magnetic resonance spectroscopy. J Neurosurgery 102 (2005) 318-327
3. Floeth F.W., Pauleit D., Langen K.J., Reifenberger G., Stoffels G., Stummer W., et al. Differentiation of tumorous and non-tumorous ring enhancing lesions (REL) with FET PET. J Nucl Med 47 (2006) 776-782
4. Grosu A.L., Weber W.A., Franz M., Stark S., Piert M., Thamm R., et al. Reirradiation of recurrent high-grade gliomas using amino acid PET(SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 511-519
5. Hamacher K., and Coenen H.H. Efficient routine production of the 18F-labelled amino acid O-2-18F fluoroethyl-L-tyrosine. Appl Radiat Isot 57 (2002) 853-856
6. Heiss P., Mayer S., Herz M., Wester H.J., Schwaiger M., and Senekowitsch-Schmidtke R. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med 40 (1999) 1367-1373
7. Jansen E.P., Dewit L.G., van Herk M., and Bartelink H. Target volumes in radiotherapy for high-grade malignant gliomas of the brain. Radiother Oncol 56 (2000) 151-156
8. Kaim A.H., Weber B., Kurrer M.O., Westera G., Schweitzer A., Gottschalk J., et al. (18)F-FDG and (18)F-FET uptake in experimental soft tissue infection. Eur J Nucl Med Mol Imaging 29 (2002) 648-654
9. Kaschten B., Stevenaert A., Sadzot B., Deprez M., Degueldre C., Del Fiore G., et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 39 (1998) 778-785
10. Langen K.J., Pauleit D., and Coenen H.H. [123I]Iodo-α-Methyl-L-Tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 29 (2002) 625-631
11. Langen K.J., Jarosch M., Muehlensiepen H., Hamacher K., Broer S., Jansen P., et al. Comparison of fluorotyrosine and methionine uptake in F98 rat gliomas. Nucl Med Biol 30 (2003) 501-508
12. Langen K.J., Hamacher K., Weckesser M., Floeth F., Stoffels G., Bauer D., et al. O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 33 (2006) 287-294
13. Mosskin M., Ericson K., Hindmarsh T., von Holst H., Collins V.P., Bergstrom M., et al. Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference. Acta Radiol 30 (1989) 225-232
14. Pauleit D., Floeth F., Herzog H., Hamacher K., Tellmann L., Müller H.W., et al. Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-L-tyrosine. Eur J Nucl Med Mol Imaging 30 (2003) 519-524
15. Pauleit D., Floeth F.W., Tellmann L., Hamacher K., Hautzel H., Müller H.W., et al. Comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET and 3-[123I]Iodo-α-Methyl-L-tyrosine (IMT) SPECT in brain tumors. J Nucl Med 45 (2004) 374-381
16. Pauleit D., Floeth F., Hamacher K., Riemenschneider M.J., Reifenberger G., Müller H.W., et al. O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with Magnetic Resonance Imaging Improves the Diagnostic Assessment of Cerebral Gliomas. Brain 128 (2005) 678-687
17. Pauleit D., Stoffels G., Schaden W., Hamacher K., Bauer D., Tellmann L., et al. PET with O-(2-[18F]fluoroethyl)-L-tyrosine (FET) in peripheral tumors: First clinical Results. J Nucl Med 46 (2005) 411-416
18. Pauleit D., Zimmermann A., Stoffels G., Bauer D., Risse J., Fluss M.O., et al. 18F-FET PET Compared with 18F-FDG PET and CT in Patients with Head and Neck Cancer. J Nucl Med 47 (2006) 256-261
19. Pöpperl G., Gotz C., Rachinger W., Gildehaus F.J., Tonn J.C., and Tatsch K. Value of O-(2-[18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma. Eur J Nucl Med Mol Imaging 31 (2004) 1464-1470
20. Pöpperl G., Goldbrunner R., Gildehaus F.J., Kreth F.W., Tanner P., Holtmannspotter M., et al. O-(2-[(18)F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma. Eur J Nucl Med Mol Imaging 32 (2005) 1018-1025
21. Pöpperl G., Kreth F.W., Herms J., Koch W., Mehrkens J.H., Gildehaus F.J., et al. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? J Nucl Med 47 (2006) 393-403
22. Pöpperl G., Gotz C., Rachinger W., Schnell O., Gildehaus F.J., Tonn J.C., et al. Serial O-(2-[(18)F]fluoroethyl)-L-tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma. Eur J Nucl Med Mol Imaging 33 (2006) 792-800
23. Rachinger W., Goetz C., Pöpperl G., Gildehaus F.J., Kreth F.W., Holtmannspotter M., et al. Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Neurosurgery 57 (2005) 505-511
24. Rau F.C., Weber W.A., Wester H.J., Herz M., Becker I., Kruger A., et al. O-(2-[18F]Fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Eur J Nucl Med Mol Imaging 29 (2002) 1039-1046
25. Ribom D., Eriksson A., Hartman M., Engler H., Nilsson A., Langstrom B., et al. Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas. Cancer 92 (2001) 1541-1549
26. Spaeth N., Wyss M.T., Weber B., Scheidegger S., Lutz A., Verwey J., et al. Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence. J Nucl Med 45 (2004) 1931-1938
27. Spaeth N., Wyss M.T., Pahnke J., Biollaz G., Lutz A., Goepfert K., et al. Uptake of (18)F-fluorocholine, (18)F-fluoro-ethyl-L tyrosine and (18)F-fluoro-2-deoxyglucose in F98 gliomas in the rat. Eur J Nucl Med Mol Imaging 33 (2006) 673-682
28. Stober B., Tanase U., Herz M., Seidl C., Schwaiger M., and Senekowitsch-Schmidtke R. Differentiation of tumour and inflammation: characterisation of [methyl-(3)H]methionine (MET) and O-(2-[ (18)F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells. Eur J Nucl Med Mol Imaging 33 (2006) Apr 8; [Epub ahead of print]
29. Weber W.A., Wester H.J., Grosu A.L., Herz M., Dzewas B., Feldmann H.J., et al. O-(2-[18F]Fluoroethyl)-L-tyrosine and L-[methyl11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med 27 (2000) 542-549
30. Weckesser M., Langen K.J., Rickert C.H., Kloska S., Straeter R., Hamacher K., et al. Initial experiences with O-(2-[18F]fluorethyl)-L-tyrosine PET in the evaluation of primary brain tumors. Eur J Nucl Med 32 (2005) 422-429
31. Wester H.J., Herz M., Weber W., Heiss P., Senekowitsch-Schmidtke R., Schwaiger M., et al. Synthesis and radiopharmacology of O-(2[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med 40 (1999) 205-212